Belch, Jill; Hiatt, William R; Baumgartner, Iris; Driver, I Vickie; Nikol, Sigrid; Norgren, Lars; Van Belle, Eric; TAMARIS Committees, ; Investigators, (2011). Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet, 377(9781), pp. 1929-37. London: Elsevier 10.1016/S0140-6736(11)60394-2
Full text not available from this repository. (Request a copy)Patients with critical limb ischaemia have a high rate of amputation and mortality. We tested the hypothesis that non-viral 1 fibroblast growth factor (NV1FGF) would improve amputation-free survival.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Baumgartner, Iris |
ISSN: |
0140-6736 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:11 |
Last Modified: |
05 Dec 2022 14:01 |
Publisher DOI: |
10.1016/S0140-6736(11)60394-2 |
PubMed ID: |
21621834 |
Web of Science ID: |
000291623200029 |
URI: |
https://boris.unibe.ch/id/eprint/2216 (FactScience: 204514) |
Actions (login required)
 |
Edit item |